Date Published: 13/04/2021
ARCHIVED - Granada pharmaceutical plant to manufacture active ingredient of Covid vaccine by Moderna
The pharmaceutical plant in Granada (Andalusia) will be the first in Spain to manufacture the active ingredient of the mRNA vaccine against coronavirus.
Rovi has announced that it will be reinforcing its collaboration towards the manufacturing of the vaccine against coronavirus made by Moderna by installing a new production line at its Granada facilities, extending the existing agreement in which vaccines delivered from Switzerland are bottled at the plant.
The pharmaceutical laboratory group based in Madrid is already involved in the formulation, bottling and final packaging of the vaccine by Moderna prior to distribution and will now be taking on a further role in the process with this latest investment.
Rovi will be creating a line capable of producing the active ingredient for more than 100 million doses of the mRNA vaccine per year and expects to start supplying markets outside the US in the third quarter of 2021.
Another Rovi plant near Madrid has already been bottling, or “filling and finishing”, Moderna vaccine ingredients being produced by Swiss drug company Lonza in Switzerland.
Once Rovi has made the drug ingredients in Granada, Moderna will decide whether the active ingredients should be bottled at Rovi in Madrid or a separate facility in France, owned by Sweden’s Recipharm.
Image: Rovi
Contact Spanish News Today: Editorial 966 260 896 /
Office 968 018 268